Component

Rat interleukin-6 / Il6

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

Read recorded mechanisms Open recursive mind map

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. IL-6 was not similarly suppressed by thymulin in LPS-challenged fetal rat alveolar type II cells.

    Thymulin → Rat interleukin-6 / Il6 Recorded from sourceungraded
    Experimental context and source evidence
    evidence_access
    Primary bibliographic record and abstract checked; full methods/figures not comprehensively reviewed.
    experimental_condition
    LPS-matched control peptide exposure · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.
    experimental_contrast
    {"intervention": "Thymulin plus LPS", "comparator": "LPS-matched control", "endpoint": "IL-6 was not similarly suppressed by thymulin in LPS-challenged fetal rat alveolar type II cells.", "effect_direction": "no_detected_change", "combination": "joint", "conditions": [{"entity_slug": "thymulin", "state": "peptide exposure"}, {"entity_slug": null, "state": "LPS challenge"}]} Explicit extracted experimental comparison; source-derived draft.
    experimental_model
    Fetal rat alveolar type II cells challenged with LPS; zinc-alone controls also affected cytokines. Distinct from the retracted hippocampal paper.
    interpretation_status
    Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
    limitations
    Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.
    plain_language
    IL-6 was not similarly suppressed by thymulin in LPS-challenged fetal rat alveolar type II cells.
    primary_references
    Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro. | 2009 | DOI 10.1016/j.molimm.2009.09.034 | PMID 19850345 | https://pubmed.ncbi.nlm.nih.gov/19850345/
    source_locator
    Reviewed reference lines 69-69; exact primary location described in quoted passage where extracted.

    Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 69–69

    Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Fetal rat alveolar type II cells challenged with LPS; zinc-alone controls also affected cytokines. Distinct from the retracted hippocampal paper. · Recorded from source · Recorded from source

    | Fetal rat alveolar type II cells challenged with LPS | Thymulin increased cAMP, reduced NF-κB nuclear signaling and reduced IL-1β release; IL-6 and TNF-α were not similarly suppressed. | Zinc alone also changed cytokine outputs. cAMP-associated effects do not identify a GPCR or establish sole mediation. This paper is not the retracted hippocampal paper discussed below. [2009 experiment](https://pubmed.ncbi.nlm.nih.gov/19850345/) |
    Complete structured claim and evidence

  2. Combined thymulin/zinc increased IL-6 in the developmental lung experiments.

    Thymulin → Rat interleukin-6 / Il6 Recorded from sourceungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract plus selected publisher results inspected; full XML not obtained.
    experimental_condition
    Matched experimental control peptide exposure · Thymulin Condition belongs to the full experimental contrast; do not separate a joint intervention.
    experimental_condition
    Matched experimental control joint zinc exposure · Zinc(II) ion Condition belongs to the full experimental contrast; do not separate a joint intervention.
    experimental_contrast
    {"intervention": "Combined thymulin and zinc", "comparator": "Matched experimental control", "endpoint": "Combined thymulin/zinc increased IL-6 in the developmental lung experiments.", "effect_direction": "increase", "combination": "joint", "conditions": [{"entity_slug": "thymulin", "state": "peptide exposure"}, {"entity_slug": "zinc-ion", "state": "joint zinc exposure"}]} Explicit extracted experimental comparison; source-derived draft.
    experimental_model
    Fetal rat lung explants; A549 cells studied separately; oxygen-dependent conditions and endpoints retained in source.
    interpretation_status
    Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
    limitations
    Interpret only within the recorded preparation, exposure and comparator. The complete source passage retains qualifications; unspecified doses/timing have not been extracted here. No clinical efficacy, nutrient deficiency or unique molecular mediation is inferred.
    plain_language
    Combined thymulin/zinc increased IL-6 in the developmental lung experiments.
    primary_references
    Thymulin evokes IL-6-C/EBPbeta regenerative repair and TNF-alpha silencing during endotoxin exposure in fetal lung explants. | 2004 | DOI 10.1152/ajplung.00401.2002 | PMID 12639846 | https://doi.org/10.1152/ajplung.00401.2002
    source_locator
    Reviewed reference lines 70-70; exact primary location described in quoted passage where extracted.

    Thymulin: detailed mechanisms of action (reviewed 3 October 2026) · lines 70–70

    Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Fetal rat lung explants; A549 cells studied separately; oxygen-dependent conditions and endpoints retained in source. · Recorded from source · Recorded from source

    | Fetal rat lung explants and A549 lung cells, oxygen-dependent conditions | Combined thymulin/zinc exposure increased IL-6 and reduced TNF protein, with p38/MAPKAPK2 and transcription-factor responses. In explants, IL-6 antisense interfered with mesenchymal growth and FGF9-associated effects. | Increased IL-6 here is a developmental response; TNF transcript and protein need separate records. Joint peptide/zinc treatment cannot automatically be attributed to peptide alone. [2004 experiment](https://doi.org/10.1152/ajplung.00401.2002) |
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.